Thyroid cancer: A review of treatment and follow-up
| Autor: | V. R. McCready, Clive Harmer, Louiza Vini |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Male
Prognostic variable medicine.medical_specialty Epidemiologic Factors Lymphoma Cancer therapy Iodine Radioisotopes Therapeutic approach Adenocarcinoma Follicular Humans Medicine Radiology Nuclear Medicine and imaging Thyroid Neoplasms Intensive care medicine Thyroid cancer Neoplasm Staging business.industry General surgery Thyroid Cancer General Medicine Prognosis medicine.disease Carcinoma Papillary Natural history medicine.anatomical_structure Carcinoma Medullary Female business Follow-Up Studies |
| Zdroj: | Annals of Nuclear Medicine. 10:1-7 |
| ISSN: | 1864-6433 0914-7187 |
| DOI: | 10.1007/bf03165047 |
| Popis: | The importance of thyroid cancers far exceeds their frequency, since they are uncommon tumours accounting for only 1% of all malignancies and for even smaller proportion of cancer deaths (0.2%). A variety of distinct tumour types arise in the thyroid gland, with variable natural histories resulting from different rates of growth and biological aggressiveness. The long natural history of the majority of thyroid neoplasms imposes a commitment for long-term follow-up and stresses the importance of planning treatment so as to avoid delayed complications that impair the quality of life of patients. The management of thyroid cancer is multidisciplinary, requiring consultation and active intervention by surgeons, endocrinologists and radiotherapists. Surgery is of paramount importance in the successful eradication of the tumours while radioiodine offers a unique therapeutic approach. Treatment must be strongly influenced by consideration of prognostic variables. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink